Neuphoria Therapeutics Inc.
NEUP
$4.12
-$0.25-5.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.91M | -8.88M | 11.26M | -1.94M | -804.80K |
| Total Depreciation and Amortization | 165.80K | 165.60K | 165.40K | 166.10K | 165.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.55M | 3.46M | 668.40K | -1.25M | -2.60M |
| Change in Net Operating Assets | 1.40M | 1.67M | -642.50K | -328.20K | -1.20M |
| Cash from Operations | -3.79M | -3.59M | 11.45M | -3.36M | -4.43M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.25M | 304.70K | 1.22M | -- | 400.00 |
| Repurchase of Common Stock | -- | -- | -- | -400.00 | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 400.00K | -61.10K | -111.20K | -227.70K |
| Cash from Financing | 3.25M | 704.70K | 1.16M | -111.60K | -227.30K |
| Foreign Exchange rate Adjustments | -19.50K | 49.60K | 85.00K | -276.70K | 138.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -560.50K | -2.83M | 12.70M | -3.75M | -4.52M |